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Reply to the Editor:
We appreciate Ji and Undar’s kind appraisal
of our study on the benefits of pulsatile car-
dioplegia in failing hearts, because their input
to the importance of pulsatile cardiopulmo-
nary bypass is well recognized.1 They pro-
pose that energy equivalent pressure (EEP)
and surplus hemodynamic energy (SHE)
should be reported when studying the effect
of pulsatile flow, because the difference be-
tween EEP and mean arterial pressure (MAP)
conveys the extra energy generated by each
pulsatile wave. EEP and MAP are identical
and the difference is zero when the pressure
wave is perfectly harmonic.
Our study did not report those values,2
because EEP and MAP were not signifi-
cantly different for the waveforms used. A
recent study by Huo and Kassab3 quantita-
tively demonstrated this point computa-
tionally, based on a full analysis of steady
state versus pulsatile flow in the entire cor-
onary arterial tree based on measured ana-
tomical data and experimentally to validate
the model. The inlet pressure waveform
measured from a porcine model was input
into an isolated heart to verify the model
predictions and showed excellent agree-
ment between the model and the experi-
ment. Mean flow of both pulsatile and
steady-state experiments and mathematical
model were not statistically different and
were consistent with normal heart micro-
sphere measurements.2 The EEP, MAP,
and SHE were 75.38 mm Hg, 73.54 mm
Hg and 1.84 mm Hg, respectively, provid-
ing only a 2.4% SHE/EEP ratio.
These calculations and this discussion
reflect why our study did not focus on the
EEP and SHE parameters. Rather, we be-
lieve that a different mechanism is at play
because changes occurred only in failing
hearts, because no significant changes were
found between pulsatile and nonpulsatile
cardioplegic flow existed in normal hearts.
More importantly, vascular resistance rose
in failing hearts in both the beating and
cardioplegic states (with and without pul-
sation) such that factors responsible for ini-
tiating such pulsatility effect, such as al-
tered number of vessels, lumen diameter,
and vascular length, must be understood as
ventricular geometry becomes expanded
and spherical. This pulsatility dependency
observation implies that dilated heart fail-
ure may have impaired coronary flow re-
serve capacity by limiting coronary auto-
regulation. This implication reinforces the
need to ensure increased perfusion pressure
during myocardial protection strategies
with the beating and pulsatile or nonpulsa-
tile cardioplegia delivery.
Here, a method of pulsatile cardioplegia
delivery was introduced to demonstrate the
capacity to overcome this limitation of
nonpulsatile cardioplegia in failing hearts.
Our findings underscore the value of coro-
nary pulsation, either by compression of
vessels by the beating heart or by internal
stretching by pulsatile cardioplegic flow.
Our findings support the work of Undar
relating to the significance of pulsatile flow
in the use of cardioplegia for cardiac pro-
tection. Furthermore, our observations re-
inforce the importance of studying models
that reflect clinical entities, such as heart
failure, because the observed enhancement
of subendocardial muscle perfusion would
have gone undetected in studies of normal
hearts.
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refers to a letter to the editor published in a
previous issue of the Journal: Kulik A,
Rubens FD, Ruel M. Intraoperative indo-
cyanine green angiography: Ready for
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Reply to the Editor:
We thank Dr. Kulik and colleagues for their
interest in our prospective study comparing
transit-time ultrasound flow (TTF) and indo-
cyanine green angiography (ICG).1 We ap-
preciate the opportunity to elaborate on the
three issues they raise:
1. Methods to improve visualization
with ICG angiography
2. Appropriate TTF criteria for graft
assessment
3. Cost Effectiveness
Regarding the first issue, indocyanine
green angiography is a method of fluores-
cent dye-contrast angiography that uses
near infrared laser as the energy source. We
have previously demonstrated poorer visu-
alization of thick pedicled arterial grafts
with this technique due to limited penetra-
tion of the laser into thicker tissues.2 To
improve visualization, we ensure that there
is no pedicle covering the area of the anas-
tomosis itself and we routinely expose the
native vessel for approximately 1 cm be-
yond the anastomosis. We do not skeleton-
ize the entire graft. Our evaluation of
patency is based on both anatomic visual-
ization of the anastomosis itself and
the opacification characteristics (ie, TIMI
flow) of the native circulation. Also, further
experience with the technique has led us to
perform selective angiograms directly into
the grafts which allows for improved visu-
alization of the distal anastomosis verses
injections into the central venous line
which can be confounded by native flow.2
Regarding the second issue, whereas
criteria for pulsatility index (PI) and dia-
stolic flow fraction (DFF) are standard,
there is little agreement on cut-off values
that distinguish between normal and abnor-
mal mean flow values. Although most sur-
geons would agree that a flow of less than
5 ml/min is definitely abnormal and will
often prompt revision, flows between 5 to
40 ml/min could potentially represent ab-
normal grafts. There is no clear consensus
regarding cutoff values that determine graft
problems and little prospective data on the
subject. The study by Di Giammarco and
colleagues, who recommend a 15 ml/min
mean flow cutoff, was retrospective in de-
sign.3 Because patients who had follow-up
angiograms were generally symptomatic,
their study design could not accurately as-
sess the false positive rate. The study by
Walpoth and colleagues, who recommend
a 20ml/min mean flow cutoff, had no an-
giographic controls to determine sensitivity
or specificity.4 In our study, surgeons were
permitted to intervene on any graft they
deemed to be poorly functioning, even if it
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